Search

Boehringer Ingelheim announces 2018 BVDzero Case Awards

Boehringer Ingelheim announces 2018 BVDzero Case Awards Boehringer Ingelheim will provide a total prize of €15,000 for the top 10 clinical cases entered Applications can be submitted on www.bvdzero.com

2024 half year results innovation progress

First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones

Patient Centricity

Our Responsibility

Human Health Our Responsibility

Ileitis prevention vaccination Lawsonia intracellularis pig

Cause, impact and prevention: Learn the essentials about Ileitis

A beginner’s guide to fighting off cat parasites

Prof. Donato Traversa explains the risk of multiparasitic infections and/or infestations in cats

Stem cell therapy for tendon and ligament injuries in horses

A tendon or ligament injury can be devastating for horse owners, riders and trainers. Our new stem cell product improves the quality of healing.

vet scholars symposium

Veterinary students and researchers from 38 veterinary schools in North America and Europe gathered at the NIH in August to discuss the future of veterinary medicine.

Boehringer Ingelheim acquires a stake in SoundTalks

Boehringer Ingelheim acquires stake in SoundTalks NV, begins pilot programme

More Potential Overview

Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.

PRRS Research Award 2022

Bridging science and veterinary practice for swine health: The winners of the European PRRS Award 2022

GARC Louis Nel interview on global rabies control

GARC’s Executive Director Professor Louis Nel shares what it takes to fight rabies.

Fight against COVID-19 pandemic

Press release on Boehringer Ingelheim's half-year figures 2020. Business development from January to June 2020.

Cat vaccination 10 things you should know

Find out how you can keep your feline companion happy and healthy.

Boehringer expands cancer research at Vienna site

Boehringer Ingelheim expands cancer research at its Vienna site

FRONTLINE becomes Brand of the Year 2019-2020

FRONTLINE becomes ‘Brand of the Year’ 2019-2020 in World Branding Awards

Brazil boosts biosecurity in dairy farms

We partnered with Embrapa to help farmers and local authorities set best practices in biosecurity for dairy through a biosecurity certificate.

Partnering with Constantia Flexibles for augmented reality

Boehringer Ingelheim partnered with Constantia Flexibles to provide an innovative packaging solution which enhances the Nutraxin packaging with augmented reality features.

Lameness horses collaboration Sleip app artificial intelligence

The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone.

new_analysis_nintedanib_SSc_ILD

Interim analysis results support long term treatment with nintedanib in SSc-ILD patients

Partnership to Develop Urea Cycle Disorders Therapy

Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders

Kicking off 2024 with five new R&D partnerships

We are kicking off 2024 with five new R&D partnerships to further enable and accelerate the company’s commitment to transform the lives of patients world-wide.

Launch of Frontline flagship store on Tmall

Boehringer Ingelheim launches Frontline flagship store on Tmall to sell selling full range of pet parasiticides.

Investment social engagements in Cowtribe veterinary startup

Last-mile veterinary delivery social start-up Cowtribe first investment of Boehringer Ingelheim Social Engagements

cat feline diabetes medication treatment eu approval

Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers